Quetiapine
Quetiapine is a second-generation (atypical) antipsychotic medication used to treat schizophrenia, bipolar disorder, and as adjunctive therapy for major depressive disorder. It works by modulating several neurotransmitter systems in the brain.
Quetiapine is an atypical antipsychotic used for schizophrenia, bipolar disorder, and as an add-on for major depression. It blocks dopamine D2 and serotonin 5-HT2A receptors. Low doses are widely used off-label for insomnia.
Uses & FDA Indications
Quetiapine is FDA-approved for several psychiatric conditions across age groups. It is a versatile agent used both as monotherapy and as part of combination regimens.
FDA-Approved Uses
- Schizophrenia — in adults and adolescents (13 and older)
- Bipolar I disorder, manic episodes — adults and pediatric patients (10 and older), as monotherapy or adjunct to lithium or divalproex
- Bipolar I disorder, depressive episodes — adults (Seroquel XR)
- Bipolar I disorder, maintenance — adults as adjunct to lithium or divalproex
- Major depressive disorder (MDD) — adjunctive therapy in adults (Seroquel XR)
Off-Label Uses
- Generalized anxiety disorder (GAD)
- Insomnia (low-dose, though not FDA-approved for this)
- Post-traumatic stress disorder (PTSD) adjunct
- Delirium management in ICU settings
How It Works
Quetiapine is a multi-receptor antagonist. Its therapeutic effects arise from blocking several neurotransmitter receptors in the central nervous system, while its side-effect profile also derives from this broad activity.
The drug and its active metabolite norquetiapine block dopamine D1 and D2 receptors (reducing psychotic symptoms), serotonin 5-HT2A receptors (improving mood and reducing extrapyramidal side effects compared to older antipsychotics), histamine H1 receptors (causing sedation and weight gain), and alpha-1 adrenergic receptors (causing orthostatic hypotension). Norquetiapine also inhibits the norepinephrine transporter, which may contribute to antidepressant effects.
Unlike older "typical" antipsychotics, quetiapine's relatively low D2 affinity and high 5-HT2A blockade are associated with a lower risk of tardive dyskinesia and extrapyramidal symptoms at therapeutic exposures.
Side Effects
Common
- Somnolence and sedation (very common, especially early in treatment)
- Dry mouth (xerostomia)
- Dizziness and orthostatic hypotension
- Constipation
- Weight gain and increased appetite
- Increased serum triglycerides and cholesterol
- Elevated blood glucose / insulin resistance
- Headache and fatigue
Serious
- Tardive dyskinesia — involuntary repetitive movements; risk increases with long-term use
- Neuroleptic malignant syndrome (NMS) — rare but life-threatening; fever, rigidity, autonomic instability
- Metabolic syndrome — diabetes mellitus, dyslipidemia, obesity
- QT interval prolongation — risk of serious cardiac arrhythmia
- Cataracts — lens changes observed in long-term animal and human studies; ophthalmologic exams recommended
- Leukopenia / neutropenia / agranulocytosis — monitor CBC in patients with low white cell counts
- Suicidal ideation — black-box warning for increased risk in children, adolescents, and young adults with psychiatric disorders
BLACK BOX WARNING: Elderly patients with dementia-related psychosis treated with antipsychotics are at an increased risk of death. Quetiapine is not approved for this use. Also carries a black-box warning regarding increased suicidal thinking in younger patients.
Drug Interactions
| Drug / Class | Interaction | Clinical Significance |
|---|---|---|
| CYP3A4 inhibitors (ketoconazole, clarithromycin, ritonavir) | Increase quetiapine plasma levels significantly; quetiapine is primarily metabolized by CYP3A4 | High — dose adjustment may be needed; avoid potent inhibitors if possible |
| CYP3A4 inducers (rifampin, carbamazepine, phenytoin, St. John's Wort) | Markedly reduce quetiapine concentrations, potentially losing therapeutic effect | High — consider alternative antipsychotic or adjust accordingly |
| CNS depressants (opioids, benzodiazepines, alcohol) | Additive sedation, respiratory depression, and psychomotor impairment | Moderate–High — use caution; avoid alcohol |
| QT-prolonging drugs (haloperidol, amiodarone, fluoroquinolones) | Additive QT prolongation; increased risk of torsades de pointes | High — avoid combination when possible; monitor ECG |
| Antihypertensives | Enhanced hypotensive effect due to alpha-1 blockade; orthostatic hypotension risk | Moderate — monitor blood pressure, especially on initiation |
| Levodopa / dopamine agonists | Quetiapine's dopamine antagonism may reduce efficacy of these agents | Moderate — use lowest effective antipsychotic exposure in Parkinson's patients |
| Lithium | Pharmacokinetic interaction minimal; monitor for additive CNS effects and QT changes | Low–Moderate — combination is clinically common; monitor |
Warnings & Contraindications
Quetiapine is contraindicated in patients with known hypersensitivity to the drug or any component of the formulation. There are no other absolute contraindications, but several serious precautions apply.
Key Precautions
- Dementia-related psychosis: Not approved; associated with increased mortality in elderly patients
- Metabolic monitoring: Baseline and periodic fasting glucose, lipids, and weight should be monitored
- Cardiovascular disease: Use caution in patients at risk for QT prolongation or with pre-existing cardiac conditions
- Seizure threshold: May lower seizure threshold; use with caution in patients with seizure disorders
- Hypothyroidism: Can reduce thyroid hormone levels; monitor TSH in long-term users
- Abrupt discontinuation: Taper slowly; abrupt stopping may cause rebound insomnia and nausea
- Pregnancy: Neonates exposed in the third trimester may experience extrapyramidal symptoms and withdrawal; weigh risk vs. benefit
Frequently Asked Questions
Why is quetiapine sometimes prescribed for sleep?
Quetiapine's strong histamine H1 receptor blockade produces marked sedation. At lower exposures, this sedative effect is prominent while antipsychotic effects are minimal. Some clinicians prescribe it off-label for insomnia, particularly in patients with comorbid mood or anxiety disorders. However, this use is controversial due to metabolic risks, potential for weight gain, and the availability of safer sleep aids.
Does quetiapine cause weight gain?
Yes. Weight gain is a well-documented side effect of quetiapine, driven largely by histamine H1 and serotonin 5-HT2C receptor blockade, which increase appetite. Metabolic consequences including elevated blood sugar and triglycerides are also common. Patients starting quetiapine should have metabolic parameters monitored regularly and discuss lifestyle strategies with their healthcare provider.
What is the difference between quetiapine IR and quetiapine XR?
The immediate-release (IR) formulation reaches peak plasma concentration in about 1.5 hours and is typically taken multiple times daily. The extended-release (XR) formulation releases the drug more gradually, reaching peak levels in about 6 hours, and is designed for once-daily administration. XR is additionally FDA-approved for major depressive disorder as an adjunct. Both formulations contain the same active compound.
Can quetiapine be stopped suddenly?
Abrupt discontinuation of quetiapine is generally not recommended. Stopping suddenly can cause rebound insomnia, nausea, and in patients with underlying psychiatric conditions, rapid return of symptoms. A gradual taper under medical supervision is the preferred approach when discontinuing the medication.
Need to identify a pill? Use the PillID visual search tool.
Identify a Pill →